head of the Sanofi Pasteur vaccines division at the French drugmaker. "Welcoming Origimm within Sanofi expands our area of expertise by bringing extensive know-how in the field of skin microbiome ...

1, 5 Thomas Grenier Head of Vaccines, North America, Sanofi "Today, we're proud to announce an important update to our label for FLUBLOK, from one of Sanofi's largest flu vaccine safety studies ...

Sanofi has announced the launch of its high-dose egg-based quadrivalent influenza vaccine (QIV-HD) in the UK. This vaccine is designed for people aged 65 and older, as well as clinically at-risk ...

"Today, we're proud to announce an important update to our label for FLUBLOK, from one of Sanofi's largest flu vaccine safety studies ever done in pregnant individuals, an important at-risk ...

Now available and can be pre-ordered for the first time for the 2025/26 flu season. Reading, UK – 15 October 2024 – Sanofi has today announced the launch of high-dose egg-based quadrivalent influenza ...

“Today, we’re proud to announce an important update to our label for FLUBLOK, from one of Sanofi’s largest flu vaccine safety studies ever done in pregnant individuals, an important at-risk population ...

Edward Jenner invented the first vaccine (the smallpox vaccine) in 1796 ... FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old. Sanofi Pasteur. Package insert - ...

GSK, Sanofi and CSL will also make additional bulk vaccine ingredients matched to circulating strains of bird flu, Boucher said. Australia's CSL recently secured a contract worth $121.4 million to ...

The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development and production activities dedicated to vaccines.